Method of Noninvasive Treatment of Diabetic Retinopathy

A method for noninvasive treatment of diabetic retinopathy, the method comprising:

• entering, by a patient, an oxygen chamber, the oxygen chamber configured to generate at least 80 percent pure oxygen, the oxygen chamber comprising a light reflective coating and a light emitting diode that emits light having a wavelength between 630 nanometers and 700 nanometers;
• breathing, by the patient, the at least 80 percent pure oxygen generated in the oxygen chamber;
• directing the light from the light emitting diode on the patient;
• administering an anti-inflammatory agent to the patient;
• administering an anti-oxidant to the patient;
• administering at least one of the following:
• an amino acid, arginine, and citrulline, to the patient;
• and
• administering an omega-3 fatty acid to the patient,
• where by the combination of treatment in the oxygen chamber and administered compositions and agents help to prevent and reverse the effects of diabetic retinopathy.

A method for noninvasive treatment of diabetic retinopathy, the method consisting of:

• entering, by a patient, a hyperbaric oxygen chamber, the hyperbaric oxygen chamber configured to generate at least 80 percent pure oxygen, the hyperbaric oxygen chamber comprising a light reflective coating and a light emitting diode that emits light having a wavelength between 630 nanometers and 700 nanometers;
• breathing, by the patient, the at least 80 percent pure oxygen generated in the oxygen chamber;
• directing the light from the light emitting diode to the closed eyelids of the patient;
• administering an anti-inflammatory agent to the patient;
• administering an anti-oxidant to the patient;
• administering at least one of the following:
• an amino acid, arginine, and citrulline, to the patient;
• administering an omega-3 fatty acid to the patient;
• administering a turmeric and an alpha-lipoic acid to the patient;
• and
• administering cold laser treatment to the patient, the cold laser treatment comprising wavelengths between 570 nanometers and 1000 nanometers, wherebythe combination of treatment in the hyperbaric oxygen chamber, the light treatment, the cold laser treatment, and the administered compositions and agents help to prevent and reverse the effects of diabetic retinopathy.